The CT20 peptide causes detachment and death of metastatic breast cancer cells by promoting mitochondrial aggregation and cytoskeletal disruption

Metastasis accounts for most deaths from breast cancer, driving the need for new therapeutics that can impede disease progression. Rationally designed peptides that take advantage of cancer-specific differences in cellular physiology are an emerging technology that offer promise as a treatment for m...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, M W, Bassiouni, R, Sparrow, N A, Iketani, A, Boohaker, R J, Moskowitz, C, Vishnubhotla, P, Khaled, A S, Oyer, J, Copik, A, Fernandez-Valle, C, Perez, J M, Khaled, A R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4047892/
https://www.ncbi.nlm.nih.gov/pubmed/24853427
http://dx.doi.org/10.1038/cddis.2014.225

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4047892/
https://www.ncbi.nlm.nih.gov/pubmed/24853427
http://dx.doi.org/10.1038/cddis.2014.225

Ejemplares similares